BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JY, Minami Y, Choi BI, Lee WJ, Chou YH, Jeong WK, Park MS, Kudo N, Lee MW, Kamata K, Iijima H, Kim SY, Numata K, Sugimoto K, Maruyama H, Sumino Y, Ogawa C, Kitano M, Joo I, Arita J, Liang JD, Lin HM, Nolsoe C, Gilja OH, Kudo M. The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. Ultrasonography 2020;39:191-220. [PMID: 32447876 DOI: 10.14366/usg.20057] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Zhao R, Cheng J. Diagnostic accuracy of contrast-enhanced ultrasound to differentiate benign and malignant breast lesions: A systematic review and meta-analysis. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110219] [Reference Citation Analysis]
2 Li L, Zheng W, Wang J, Han J, Guo Z, Hu Y, Li X, Zhou J. Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection. AJR Am J Roentgenol 2022. [PMID: 35441534 DOI: 10.2214/AJR.22.27521] [Reference Citation Analysis]
3 Jeon SK, Lee JY, Han JK. Superb microvascular imaging technology of ultrasound examinations for the evaluation of tumor vascularity in hepatic hemangiomas. Ultrasonography 2021;40:538-45. [PMID: 33866773 DOI: 10.14366/usg.20177] [Reference Citation Analysis]
4 Numata K. Contrast-enhanced ultrasound as noninvasive diagnostic images that anyone can easily understand. J Med Ultrason (2001) 2020;47:341-5. [PMID: 32661743 DOI: 10.1007/s10396-020-01031-9] [Reference Citation Analysis]
5 Minami Y, Minami T, Ueshima K, Yagyu Y, Tsurusaki M, Okada T, Hori M, Kudo M, Murakami T. Three-Dimensional Radiological Assessment of Ablative Margins in Hepatocellular Carcinoma: Pilot Study of Overlay Fused CT/MRI Imaging with Automatic Registration. Cancers (Basel) 2021;13:1460. [PMID: 33806751 DOI: 10.3390/cancers13061460] [Reference Citation Analysis]
6 Sun Y, Cui L, Wang S, Shi T, Hao Y, Lei Y. Comparative study of two contrast agents for intraoperative identification of sentinel lymph nodes in patients with early breast cancer. Gland Surg 2021;10:1638-45. [PMID: 34164308 DOI: 10.21037/gs-21-87] [Reference Citation Analysis]
7 Marschner CA, Rübenthaler J, Froelich MF, Schwarze V, Clevert DA. Benefits of contrast-enhanced ultrasonography for interventional procedures. Ultrasonography 2021;40:207-16. [PMID: 33530676 DOI: 10.14366/usg.20083] [Reference Citation Analysis]
8 Yusefi H, Helfield B. Ultrasound Contrast Imaging: Fundamentals and Emerging Technology. Front Phys 2022;10:791145. [DOI: 10.3389/fphy.2022.791145] [Reference Citation Analysis]
9 Minami Y, Kudo M. Image Guidance in Ablation for Hepatocellular Carcinoma: Contrast-Enhanced Ultrasound and Fusion Imaging. Front Oncol 2021;11:593636. [PMID: 33747913 DOI: 10.3389/fonc.2021.593636] [Reference Citation Analysis]
10 Marschner CA, Geyer T, Froelich MF, Rübenthaler J, Schwarze V, Clevert DA. Diagnostic Value of Contrast-Enhanced Ultrasound for Evaluation of Transjugular Intrahepatic Portosystemic Shunt Perfusion. Diagnostics (Basel) 2021;11:1593. [PMID: 34573935 DOI: 10.3390/diagnostics11091593] [Reference Citation Analysis]
11 Wang F, Numata K, Nihonmatsu H, Chuma M, Moriya S, Nozaki A, Ogushi K, Fukuda H, Ruan L, Okada M, Luo W, Koizumi N, Nakano M, Otani M, Inayama Y, Maeda S. Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablation. Int J Hyperthermia 2020;37:1149-58. [PMID: 32996799 DOI: 10.1080/02656736.2020.1825837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hwang JA, Jeong WK, Kang HJ, Lee ES, Park HJ, Lee JM. Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma. Eur Radiol 2022. [PMID: 35705829 DOI: 10.1007/s00330-022-08900-6] [Reference Citation Analysis]
13 Hui TC, Kwan J, Pua U. Advanced Techniques in the Percutaneous Ablation of Liver Tumours. Diagnostics (Basel) 2021;11:585. [PMID: 33805107 DOI: 10.3390/diagnostics11040585] [Reference Citation Analysis]
14 Li X, Han X, Li L, Su C, Sun J, Zhan C, Feng D, Cheng W. Dynamic Contrast-Enhanced Ultrasonography with Sonazoid for Diagnosis of Microvascular Invasion in Hepatocellular Carcinoma. Ultrasound in Medicine & Biology 2021. [DOI: 10.1016/j.ultrasmedbio.2021.11.005] [Reference Citation Analysis]
15 Kyung Jeon S, Young Lee J, Kang H, Koo Han J. Additional value of superb microvascular imaging of ultrasound examinations to evaluate focal liver lesions. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110332] [Reference Citation Analysis]
16 Chung J, Lee YJ, Choi YJ, Ha EJ, Suh CH, Choi M, Baek JH, Na DG; Korean Society of Thyroid Radiology (KSThR)., Korean Society of Radiology. Clinical applications of Doppler ultrasonography for thyroid disease: consensus statement by the Korean Society of Thyroid Radiology. Ultrasonography 2020;39:315-30. [PMID: 32892523 DOI: 10.14366/usg.20072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Saito A, Yamamoto M, Katagiri S, Yamashita S, Nakano M, Morizane T. Early hemodynamics of hepatocellular carcinoma using contrast-enhanced ultrasound with Sonazoid: focus on the pure arterial and early portal phases. Glob Health Med 2020;2:319-27. [PMID: 33330827 DOI: 10.35772/ghm.2020.01092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Sandulescu LD, Urhut CM, Sandulescu SM, Ciurea AM, Cazacu SM, Iordache S. One stop shop approach for the diagnosis of liver hemangioma. World J Hepatol 2021; 13(12): 1892-1908 [DOI: 10.4254/wjh.v13.i12.1892] [Reference Citation Analysis]
19 Hwang JA, Jeong WK, Min JH, Kim YY, Heo NH, Lim HK. Sonazoid-enhanced ultrasonography: comparison with CT/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma. Ultrasonography 2021;40:486-98. [PMID: 33745266 DOI: 10.14366/usg.20120] [Reference Citation Analysis]